Priority Date: 20.02.13 (US 201361766830P)

TREATMENT OF GRAFT VERSUS HOST DISEASE IN TRANSPLANT PATIENTS

  • Application ID: EP14708330
  • Status: EXAMINATION REQUESTED

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
1 office
Technology Company
Employment test 51 - 200 employees
Company dna vossius and partner
operating since 1961
Headquarter in Munich and 3 offices
active in Legal Services and IP-related Communication Service

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Vossius & Partner Patentanwälte Rechtsanwälte mbB and Novartis Pharma AG are specialized in A61. Novartis Pharma AG is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 20.02.2013 - Priority Date (US 201361766830P)
  • 28.08.2014 - Publication A1 (WO2014128611)
  • 30.12.2015 - Publication A1 (EP2958624)